Document is current
Any future updates will be listed below
-
Authors
Avella, Dennisse https://orcid.org/0009-0003-9645-5164
Turunen, Soile https://orcid.org/0000-0001-8063-8503
Avgerinou, Glykeria https://orcid.org/0009-0005-3274-6979
Petridou, Anatoli https://orcid.org/0000-0002-5060-1950
Mougios, Vassilis https://orcid.org/0000-0002-8430-7231
Zarei, Iman https://orcid.org/0000-0002-9560-2631
Auriola, Seppo https://orcid.org/0000-0002-4580-1034
Hanhineva, Kati https://orcid.org/0000-0001-6834-7375
Kärkkäinen, Olli https://orcid.org/0000-0003-0825-4956
-
Funding
Funding for this research was provided by:
European Commission – HORIZON 2021, Marie Skłodowska Curie actions (101073062)
European Commission – HORIZON 2021, Marie Skłodowska Curie actions (101073062)
European Commission – HORIZON 2021, Marie Skłodowska Curie actions (101073062)
European Commission – HORIZON 2021, Marie Skłodowska Curie actions (101073062)
European Commission – HORIZON 2021, Marie Skłodowska Curie actions (101073062)
- License Information
-
More Information
Article History
Received: 2 July 2025
Accepted: 16 March 2026
First Online: 29 May 2026
Declarations
:
: OK and KH are founders of Afekta Technologies Ltd., a company providing metabolomics analysis services. All other authors report no conflict of interest.
: The study was approved by the Research Ethics Committee of the Aristotle University of Thessaloniki (#306272/2022). All procedures performed in studies involving human participants followed the ethical standards of the institutional and/or national research committee and the 1964 Helsinki Declaration and its later amendments, or comparable ethical standards. Before sample collection, informed consent was obtained from all individual participants included in the study.
